Shanghai ChemPartner Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shanghai ChemPartner Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10840
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai ChemPartner Co Ltd (ChemPartner) is a life science contract research organization. The organization’s services include manufacturing of small molecules and biologics, drug discovery and development, biomarkers, preclinical and clinical sample bioanalysis, and analytical services, among others. It offers its services in the areas of biologics, chemistry, biology, drug metabolism pharmacokinetic and exploratory toxicology. ChemPartner holds expertise in therapeutic areas of oncology, pathology, neuroscience, tumor immunology, neuroscience, cell biology, epigenetics and metabolic disorders. The organization provides its custom research services to pharmaceutical and biotechnology companies. It has its operations in Denmark, Japan and the US. ChemPartner is headquartered in Pudong, China.

Shanghai ChemPartner Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai ChemPartner Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Berkeley Lights Enters into Co-Development Agreement with Shanghai ChemPartner 11
Link Health Enters into Research Agreement with Shanghai ChemPartner 12
ChemPartner Enters into Co-Development Agreement with Active Motif 13
Merger 14
Shanghai ChemPartner Merges with Quantum Hi-Tech (China) Biological 14
Licensing Agreements 15
Huabobio Enters Into Licensing Agreement With ChemPartner 15
Acquisition 16
Quantum Hi-Tech China Biological to Acquire Shanghai ChemPartner 16
Shanghai ChemPartner Co Ltd – Key Competitors 17
Shanghai ChemPartner Co Ltd – Key Employees 18
Shanghai ChemPartner Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Mar 24, 2017: ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai ChemPartner Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai ChemPartner Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Berkeley Lights Enters into Co-Development Agreement with Shanghai ChemPartner 11
Link Health Enters into Research Agreement with Shanghai ChemPartner 12
ChemPartner Enters into Co-Development Agreement with Active Motif 13
Shanghai ChemPartner Merges with Quantum Hi-Tech (China) Biological 14
Huabobio Enters Into Licensing Agreement With ChemPartner 15
Quantum Hi-Tech China Biological to Acquire Shanghai ChemPartner 16
Shanghai ChemPartner Co Ltd, Key Competitors 17
Shanghai ChemPartner Co Ltd, Key Employees 18
Shanghai ChemPartner Co Ltd, Other Locations 19
Shanghai ChemPartner Co Ltd, Subsidiaries 19

List of Figures
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai ChemPartner Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai ChemPartner Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Shanghai ChemPartner Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Endo International Plc (ENDP)-医療機器分野:企業M&A・提携分析
    Summary Endo International Plc (Endo) is a specialty healthcare company that develops, manufactures and commercializes various branded pharmaceutical products, generic pharmaceuticals and other products through its operating companies including Endo Pharmaceuticals, Paladin Labs, Par Pharmaceutical, …
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Sports Direct International Plc:企業の戦略・SWOT・財務情報
    Sports Direct International Plc - Strategy, SWOT and Corporate Finance Report Summary Sports Direct International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Steel Authority Of India Ltd:企業の戦略・SWOT・財務分析
    Steel Authority Of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority Of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aragen Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aragen Bioscience Inc (Aragen), a subsidiary of GVK Biosciences Inc, is a contract research organisation that provides preclinical contract research and development services. The company provides recombinant cell line and hybridoma development, cell culture and protein purification process d …
  • Fagron NV:企業のM&A・事業提携・投資動向
    Fagron NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fagron NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Mayo Clinic:製薬・医療:M&Aディール及び事業提携情報
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • Saras SpA (SRS):石油・ガス:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Nippon Sheet Glass Company Limited :企業の戦略・SWOT・財務情報
    Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • J. Front Retailing Co Ltd:企業の戦略・SWOT・財務分析
    J. Front Retailing Co Ltd - Strategy, SWOT and Corporate Finance Report Summary J. Front Retailing Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Chesapeake Energy Corporation (CHK)-石油・ガス分野:企業M&A・提携分析
    Summary Chesapeake Energy Corporation (Chesapeake) is an upstream oil and gas company. The company explores develops and produces oil and gas from its assets. It has liquid operations in Eagle Ford Shale; the Utica Shale; the Granite Wash, Cleveland, Tonkawa and Mississippian Lime plays in the Anada …
  • Curtiss-Wright Corp (CW):電力:M&Aディール及び事業提携情報
    Summary Curtiss-Wright Corp (Curtiss-Wright) is a manufacturing and service company. It designs, manufactures, and overhauls precision components and provides highly engineered critical function products. The company also provides support services for critical applications. Curtiss-Wright serves cus …
  • Central Garden & Pet Co (CENT):企業の財務・戦略的SWOT分析
    Central Garden & Pet Co (CENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Goldin Properties Holdings Ltd:企業の戦略・SWOT・財務分析
    Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Islet Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Islet Sciences Inc (Islet Sciences) is a drug development company that develops medicines and technologies for the treatment of metabolic diseases. The company's pipeline products include immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflamma …
  • Caprion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Caprion Biosciences Inc (Caprion) is a provider of proteomics and immune monitoring services. The company provides proteomic based services such as neo-epitope discovery and characterization, biomarker discovery, fit-for-purpose assays, host cell protein detection, PK assays, and others. It …
  • Incitec Pivot Ltd (IPL):企業の財務・戦略的SWOT分析
    Incitec Pivot Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Avanir Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avanir Pharmaceuticals Inc (Avanir) a subsidiary of Otsuka America, Inc. is a biopharmaceutical company which focuses on developing medicines for patients suffering from central nervous system disorders. The company’s lead products include NUEDEXTA (AVP-923), a first-in-class dual N-methyl-D …
  • Neuland Laboratories Ltd (NEULANDLAB)-製薬・医療分野:企業M&A・提携分析
    Summary Neuland Laboratories Ltd (Neuland Lab), a subsidiary of Neuland Health Sciences Pvt Ltd is an API manufacturing service provider that manufactures active pharmaceutical ingredients, advanced intermediates; and offers chemistry related services. The company offers APIs in various therapeutic …
  • Synthonics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Synthonics Inc (Synthonics) is a pharmaceutical company that discovers, develops and licenses metal coordinated pharmaceuticals. The company uses unique metal coordination chemistry for modifying specific properties of patent-expiring pharmaceuticals. It develops MCP-311, a drug candidate th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆